Jpmorgan Chase & CO Phibro Animal Health Corp Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,585 shares of PAHC stock, worth $248,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,585
Previous 11,339 2.17%
Holding current value
$248,614
Previous $255,000 4.71%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$20.89 - $25.55 $5,138 - $6,285
246 Added 2.17%
11,585 $243,000
Q3 2024

Dec 26, 2024
BUY
$16.39 - $22.5 $1,573 - $2,160
96 Added 0.85%
11,339 $255,000
Q3 2024

Nov 08, 2024
BUY
$16.39 - $22.5 $1,573 - $2,160
96 Added 0.85%
11,339 $255,000
Q2 2024

Dec 26, 2024
SELL
$12.44 - $18.55 $1,194 - $1,780
-96 Reduced 0.85%
11,243 $188,000
Q2 2024

Aug 12, 2024
SELL
$12.44 - $18.55 $66,267 - $98,815
-5,327 Reduced 32.15%
11,243 $188,000
Q1 2024

Dec 26, 2024
BUY
$10.63 - $13.68 $55,605 - $71,560
5,231 Added 46.13%
16,570 $214,000
Q1 2024

May 10, 2024
SELL
$10.63 - $13.68 $900,339 - $1.16 Million
-84,698 Reduced 83.64%
16,570 $214,000
Q4 2023

Dec 26, 2024
BUY
$9.59 - $12.91 $862,419 - $1.16 Million
89,929 Added 793.09%
101,268 $1.17 Million
Q4 2023

Feb 12, 2024
BUY
$9.59 - $12.91 $149,632 - $201,434
15,603 Added 18.21%
101,268 $1.17 Million
Q3 2023

Nov 14, 2023
BUY
$12.43 - $15.29 $858,117 - $1.06 Million
69,036 Added 415.15%
85,665 $1.09 Million
Q2 2023

Aug 11, 2023
SELL
$12.92 - $15.89 $324,692 - $399,331
-25,131 Reduced 60.18%
16,629 $227,000
Q1 2023

May 18, 2023
BUY
$13.67 - $16.37 $213,580 - $255,764
15,624 Added 59.78%
41,760 $639,000
Q1 2023

May 11, 2023
SELL
$13.67 - $16.37 $167,758 - $200,892
-12,272 Reduced 31.95%
26,136 $400,000
Q4 2022

Feb 13, 2023
SELL
$12.05 - $15.14 $16,713 - $20,999
-1,387 Reduced 3.49%
38,408 $515,000
Q3 2022

Nov 14, 2022
SELL
$12.82 - $20.22 $3,115 - $4,913
-243 Reduced 0.61%
39,795 $529,000
Q2 2022

Aug 11, 2022
SELL
$17.89 - $20.47 $25,582 - $29,272
-1,430 Reduced 3.45%
40,038 $766,000
Q1 2022

May 11, 2022
SELL
$18.39 - $21.85 $744,408 - $884,466
-40,479 Reduced 49.4%
41,468 $828,000
Q4 2021

Feb 10, 2022
SELL
$18.96 - $22.76 $49,125 - $58,971
-2,591 Reduced 3.06%
81,947 $1.67 Million
Q3 2021

Nov 12, 2021
BUY
$20.59 - $30.01 $1.74 Million - $2.54 Million
84,538 New
84,538 $1.82 Million

Others Institutions Holding PAHC

# of Institutions
176
Shares Held
20.6M
Call Options Held
0
Put Options Held
0
View Full List

About PHIBRO ANIMAL HEALTH CORP

PAHC Quotes by TradingView
  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $436M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email